TipRanks
Cellectar Biosciences (DE:NV40)
FRANKFURT:NV40
Germany Market
NV40
Cellectar Biosciences
RESEARCH TOOLSreports

Cellectar Biosciences (NV40) Balance Sheet

1 Followers

Cellectar Biosciences Balance Sheet

Cellectar Biosciences's total assets for Q2 2026 were $36.64M, an increase of 229.50% from the previous quarter. DE:NV40 total liabilities were $6.77M for the fiscal quarter, a 5.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 14.98M$ 25.47M$ 12.08M$ 21.59M$ 37.20M
Total Liabilities
$ 5.06M$ 11.18M$ 25.85M$ 12.05M$ 4.16M
Total Equity Gross Minority
$ 9.92M$ 14.29M$ -13.78M$ 9.54M$ 33.05M
Other Metrics
Currency in USD

Cellectar Biosciences Debt to Assets